Artwork

Innhold levert av Van Richards, ChFC® and Van Richards. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Van Richards, ChFC® and Van Richards eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Daily Stock Analysis – Pfizer is the top COVID-19 vaccine maker. How are earnings affected?

27:15
 
Del
 

Manage episode 282330130 series 2852122
Innhold levert av Van Richards, ChFC® and Van Richards. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Van Richards, ChFC® and Van Richards eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Daily Stock Analysis – Pfizer is the top COVID-19 vaccine maker. How are earnings affected?

Many people only know Pfizer as a COVID-19 vaccine maker. Their vaccine could turn the tide against the spread of the coronavirus. But how much will that affect their earnings? With six business units, vaccines are only one. Plus, it is not the most profitable. Are they undervalued, and what does their future look like? That is what I am talking about today on the Daily Stock Analysis.

If you'd like to view this episode or previous episodes, visit https://youtu.be/mE8iS0ORY6M
Additionally, if you are in Texas and you're frustrated with your personal financial growth, I have a new program for that called the Prosperous Planning Process. Learn more about turning a lack of financial control into abundance at https://richardsfinancialplanning.com/

One last point from our sponsor, Advice4LifeInsurance.com. If you need life insurance,
you can find the best life insurance at the lowest price in less than five minutes. Visit their website at https://www.advice4lifeinsurance.com
#coronavirus #healthcare #pharmaceuticals

  continue reading

26 episoder

Artwork
iconDel
 
Manage episode 282330130 series 2852122
Innhold levert av Van Richards, ChFC® and Van Richards. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Van Richards, ChFC® and Van Richards eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Daily Stock Analysis – Pfizer is the top COVID-19 vaccine maker. How are earnings affected?

Many people only know Pfizer as a COVID-19 vaccine maker. Their vaccine could turn the tide against the spread of the coronavirus. But how much will that affect their earnings? With six business units, vaccines are only one. Plus, it is not the most profitable. Are they undervalued, and what does their future look like? That is what I am talking about today on the Daily Stock Analysis.

If you'd like to view this episode or previous episodes, visit https://youtu.be/mE8iS0ORY6M
Additionally, if you are in Texas and you're frustrated with your personal financial growth, I have a new program for that called the Prosperous Planning Process. Learn more about turning a lack of financial control into abundance at https://richardsfinancialplanning.com/

One last point from our sponsor, Advice4LifeInsurance.com. If you need life insurance,
you can find the best life insurance at the lowest price in less than five minutes. Visit their website at https://www.advice4lifeinsurance.com
#coronavirus #healthcare #pharmaceuticals

  continue reading

26 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett